{"id":"NCT00423605","sponsor":"Jazz Pharmaceuticals","briefTitle":"Safety and Efficacy Study of Xyrem速 (Sodium Oxybate) in Subjects With Fibromyalgia.","officialTitle":"A Long-Term, Open-Label, Safety and Efficacy Study of Xyrem速 (Sodium Oxybate) in Subjects With Fibromyalgia.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2007-01-18","resultsPosted":"2011-10-20","lastUpdate":"2012-03-30"},"enrollment":560,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"Xyrem速","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"The objective of this trial is to evaluate the safety and efficacy of Xyrem速 in long term use.","primaryOutcome":{"measure":"Number of Subjects Reporting Adverse Events","timeFrame":"Treatment Period (38 weeks)","effectByArm":[{"arm":"Xyrem 4.5 g to 9.0 g","deltaMin":498,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":91,"countries":["United States","France","Germany","Italy","Netherlands","Spain","United Kingdom"]},"refs":{"pmids":["24286114"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":560},"commonTop":["Nausea","Headache","Dizziness","Nasopharyngitis","Vomiting"]}}